LACREON® Technology provides a long-lasting cushion of moisture for 20 hours or more.3
1-DAY ACUVUE® MOIST contact lenses block ~97% of UVB and ~82% of UVA4.
| Title | Description |
|---|---|
Lens Material | Etafilcon A |
Technology | LACREON® Technology |
Dk/t∞§4 (edge-corrected) | 25.5 x 10-9 |
Water Content | 58% |
UV BLocking – Class 2#^4 | ~97% UVB and 82% UVA |
Centre thickness at -3.00D | 0.084mm |
Base Curve | 8.5mm, 9.0mm |
Diameter | 14.2mm |
Power Range | -0.50D to -6.00D (0.25D steps) -6.50D to -12.00D (0.50D steps) +0.50D to +6.00D (0.25D steps) |
Visibility Tint | Yes |
Replacement Schedule | Daily Disposable |
Package Size | 30 and 90 Packs |
The 1-DAY ACUVUE® MOIST family of lenses provides a wide range of parameters to satisfy the vision needs of spherical, astigmatic, and presbyopic patients††6
LACREON® Technology is a unique Dual Action Technology designed to keep moisture in and irritation out with an embedded wetting agent (PVP) that won’t blink away or release over time.‡3,7
ACUVUE® soft contact lenses have thin edges so that the eyelids glide over them as if nothing is there.8
UV blocking in every lens to help protect eyes from the transmission of harmful UV radiation.#^4
Help protect the ocular environment from oxidative effects that may contribute to discomfort.9
$ In a year-long observational/surveillance registry that relied on patient reports of symptomatic adverse events that would have led them to seek clinical care, no symptomatic infiltrative events or serious adverse events were reported. These results should be considered in conjunction with other clinical results on the safety and efficacy of daily disposable etafilcon A contact lenses, which also generally show low rates of such events. Although no symptomatic infiltrative events were reported in this study, such events can and have occurred with daily disposable lenses, including 1-DAY ACUVUE® MOIST, as noted in the product labeling.
+ 14 clinical studies posted on ClinicalTrials.gov, a website maintained by the NIH, evaluated subjective comfort as a primary or secondary endpoint for 1-DAY ACUVUE® MOIST Brand family (spherical, astigmatism, and multifocal) contact lenses vs. competitors’ products. Published trials include comparisons between etafilcon A and nelfilcon A, omafilcon A, hilafilcon B, ocufilcon D and nesofilcon A. Review conducted as of October 31, 2025.
# Helps protect against transmission of harmful UV radiation to the cornea & into the eye.
^ WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care professional for more information.
∞ MPa values calculated from psi measured values
§ Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses.† Based on in-vitro data, clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.
†† Based on publicly available manufacturer information as of March 2020
‡ The release profile for PVP in 1-DAY ACUVUE® MOIST over 24 hours demonstrated no detectable amount of PVP released throughout the 24-hour simulated wear period.
REFERENCES
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-267-5098 or by visiting www.jnjvisionpro.com/en-ca/.
2025PP16984
